Allergies
Cytos' Allergy Vaccine Shows Long-Term Efficacy
Filed in archive Allergy: Research and Development , Hay Fever , Insect Allergies by ruth on April 29, 2006
Cytos' Allergy Vaccine Shows Long-Term Efficacy
Suffering from dust-mite allergies? Hang on, there's hope for a long-term treatment: a vaccine being developed is on track.

Cytos Biotechnology AG announced
today positive follow-up results from its phase IIa study with CYT005-AllQbG10 to treat allergic
diseases. The phase IIa trial in 20 patients with allergic rhinoconjunctivitis and asthma due to house
dust mite allergy evaluated the safety, tolerability and exploratory efficacy of a 10 week treatment with 300g CYT005-AllQbG10 in conjunction with house dust mite allergen.
The follow-up results obtained 8 months after start of treatment (i.e. 24 weeks after the last
injection) show that the powerful efficacy achieved with CYT005-AllQbG10 treatment offers
significant therapeutic benefit for an extended period of time.


Of course, the drug is just under Phase 2 trials. It's still a long wait til it finds its way to the drugstore, if at all.

[Soource: Cytos, pdf file]

Permalink: Cytos' Allergy Vaccine Shows Long-Term Efficacy
Tags: vaccine  dust 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/21030
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Cytos' Allergy Vaccine Shows Long-Term Efficacy:

  • Currently 8.40/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.40 out of 5 vote(s) cast.
 
Subscribe
Share It
Popular posts from our other blogs:
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!